Possible mechanisms of bcg immuno therapy tumor specific immunity and cross reacting antigens of bcg and tumor cell surface
Hanna, M.G.Jr; Bucana, C.
Crispen, Ray G (Ed ) Neoplasm Immunity: Theory And Application Proceedings Of A Chicago Symposium Chicago, Ill , U S A , Sept 11, 1974 Vii+204p Illus Itr Biomedical Research, University Of Illinois: Chicago, Ill , U S A ISBN 0-915314-02-9: 65-85
1975
Accession: 027176786
PDF emailed within 1 workday: $29.90
Related References
Ting, C.C.; Rodrigues, D.; Nordan, R. 1982: Studies of the mechanisms for the induction of in vivo tumor immunity. VI. Induction of specific and nonspecific cell-mediated immunity in tumor-bearing hosts and its correlation with transplantation tumor immunity Cellular Immunology 66(1): 45-58Berkman, J.I.; Mesa Tejada, R.; Klavins, J.V.; Weiss, M. 1975: Demonstration of cross reacting human tumor antigens by immuno peroxidase staining technique Federation Proceedings 34(3): 834
Hui, K.M.; Kim, B.S. 1984: Tumor-specific immunity induced by somatic hybrids. IV. Relationship between immunogenicity and expression of surface tumor-associated antigens Cellular Immunology 87(2): 591-600
Ankerst, J.; Sjögren, H.O. 1970: Cross-reacting tumor-specific transplantation of antigens in tumors induced by adenoviruses, 3, 14, and 12 Cancer Research 30(5): 1499-1505
Holmes, E.C.; Morton, D.L.; Schidlovsky, G.; Trahan, E. 1971: Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas Journal of the National Cancer Institute 46(4): 693-700
Schroit, A.J.; Key, M.E. 1983: Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens Immunology 49(3): 431-438
Meltzer, M.S.; Oppenheim, J.J.; Littman, B.H.; Leonard, E.J.; Rapp, H.J. 1972: Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens Journal of the National Cancer Institute 49(3): 727-734
Rao, V.S.; Bonavida, B. 1976: Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens Cancer Research 36(4): 1384-1391
Sasaki J I.; Fukushi, K.; Ueki, T. 1981: Immuno therapy of malignant tumor with bacterial endo toxin cell mediated immunity in tumor bearing guinea pig Hirosaki Medical Journal 33(3): 475-483
Baldwin, R.W. 1978: Studies on 2 tumor immuno therapy models induction of specific systemic immunity and immuno stimulation by dermal application of adjuvant British Journal Of Cancer: 189
Sano, S.; Izumi, Y.; Sugihara, S.; Nakajima, H.; Fujiwara, H.; Hamaoka, T. 1987: The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens Cancer Immunology Immunotherapy: Cii 25(2): 105-110
Brown, M.D.; van der Most, R.; Vivian, J.B.; Lake, R.A.; Larma, I.; Robinson, B.W.S.; Currie, A.J. 2012: Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity Oncoimmunology 1(7): 1084-1094
Kumar, S.; Waghe, M.; Taylor, G. 1977: Tumour-specific antibodies reactive with cell-surface antigens in children with Wilms' tumour International Journal of Cancer 19(3): 351-355
Dai, J.; Liu, B.; Caudill, M.M.; Zheng, H.; Qiao, Y.; Podack, E.R.; Li, Z. 2003: Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory Cancer Immunity 3: 1
Nishioka, K.; Irie, R.F.; Kawana, T.; Takeuchi, S. 1969: Immunological studies on mouse mammary tumors. 3. Surface antigens reacting with tumor-specific antibodies in immune adherence International Journal of Cancer 4(2): 139-149